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Background: Mutations in HPCA, a gene implicated in calcium signaling in the striatum,
have been recently described in recessive dystonia cases previously grouped under the
term “DYT2 dystonia”. Positive patients reported so far show focal onset during childhood
with subsequent generalization and a slowly progressive course to adulthood.
Methods: 73 patients with isolated dystonia of various distribution, manifesting within 21
years of age, were enrolled in this Italian study and underwent a mutational screening of
HPCA gene by means of Sanger sequencing.
Results/conclusions: Meanage at onsetwas 10.2 (±5.1) years andmeanage at the timeof genetic
testing was 33 (±14.2) years. Mean disease duration at the time of enrollment was 22.7 (±12.8)
years. None of the patients enrolledwas found to carryHPCAmutations, rising suspicion that
theseprobably representavery rarecauseofdystonia inchildhood-adolescence.Largerstudies
will helpdetermining the realmutational frequencyof thisgenealso indifferentethnicgroups.
© 2016 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights
reserved.1. Introduction
Dystonia is a hyperkinetic movement disorder characterized
by sustained or intermittent muscle contractions causingetics Unit, IRCCS Founda
to-besta.it (B. Garavaglia)
logy Society. Published babnormal, often repetitive, movements, postures, or both.
Dystonia is often initiated or worsened by voluntary action
and associated with overflow muscle activation. Dystonia is
defined “isolated” if no additional neurological abnormalitiestion C. Besta Neurological Institute, Via L. Temolo, 4, 20126 Milan,
.
y Elsevier Ltd. All rights reserved.
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In the current classification by Albanese et al.,1 the age to
discriminate between childhood- and adult-onset dystonia
has been set at 21 years and a detailed categorization has
been adopted, subdividing the age at onset as follows: infancy
(birth to 2 years); childhood (3e12 years); adolescence (13e20
years); early adulthood (21e40 years); late adulthood (>40
years).
Isolated dystonia in children has a wide differential diag-
nosis, and early-onset cases generally differ from late-onset
ones in terms of anatomical sites affected and rate of gener-
alization; in fact, children and adolescents often show an
initial lower limb involvement with a high tendency to spread
to other body sites, while adult-onset dystonia commonly
remains focal (e.g. blepharospasm) or segmental.
Most genetically inherited dystonias show an autosomal
dominant mode of inheritance with reduced penetrance and
variable expressivity.2 However, a few families of different
ethnical background have been described in which dystonia is
recessively inherited. Some of themwere collectively grouped
under the umbrella term “DYT2” or “DYT2-like” dystonia,3,4
whereas “DYT17” refers to a locus mapped on chromosome
20p11.2-q13.12 in a single Lebanese family.5
Thanks to Next Generation Sequencing (NGS) techniques,
the identification of dystonia-related genes has significantly
improved in recent years, making it possible to formulate a
definite genetic diagnosis in an increasing proportion of pa-
tients. In 2015, using a combination of homozygosity mapping
and whole exome sequencing, Charlesworth et al.6 identified
mutations in Hippocalcin (HPCA) as the cause of DYT2 early-
onset recessive dystonia in a previously-published Sephardic
Jewish kindred from Iran3 and in an additional unrelated case
from Sri Lanka. HPCA encodes a neuronal calcium sensor
protein expressed mainly in the striatum which exerts its
Ca2þ-dependent activity by interacting with downstream
proteins still under investigation; perturbation of calcium
signaling and neuronal excitability has thus been proposed as
an important mechanism in the pathogenesis of this kind of
genetic dystonia.
The frequency of HPCA mutations in isolated dystonia is
unknown and the only available genetic screening investi-
gating it,7 including a heterogeneous population of patients
with dystonia has been recently published, failing to identify
new positive cases.
However, no studies focusing only on pediatric-onset
dystonia are available. In this paper, we screened a cohort of
genetically undefined isolated dystonia cases for HPCA mu-
tations, focusing on patients with onset from infancy to
adolescence, namely within 21 years of age.2. Methods
Patients previously referred either to the Carlo Besta Neuro-
logical Institute, Milan, or the Mendel Institute, Rome for
clinical assessment of dystonia were included in this study.
Subjects with isolated dystonia with various distribution and
onset before 21 years of age, lacking a definite genetic diag-
nosis were enrolled. All patients tested negative for the
recurrent GAG deletion of the DYT1/TOR1A gene. Moreover, inall patients Dopa-Responsive Dystonia (DRD) had been previ-
ously ruled out either genetically, on the basis of cerebrospinal
fluid neurotransmitter profile or on clinical grounds after an
appropriate Levodopa trial. Among patients enrolled, 34 also
tested negative for mutations in the PRKRA gene (DYT16), a
rare cause of early-onset, recessive dystonia-parkinsonism
described in few families so far, which can be characterized
only by dystonia at onset and for several years over the dis-
ease course.8
After obtaining informed consent, the subjects included in
this study were blood sampled and DNA was extracted from
peripheral blood lymphocytes according to standard proced-
ures. In some cases genetic analysis was performed after a
long disease history, thanks to the availability of patients'
DNA in our biobank. Also in these cases, patients' consent was
retrieved. All exons and flanking intronic regions of HPCA
were Sanger sequenced (primer sequences and conditions
available upon request e disturbimovimento@istituto-besta.
it). Clinical and demographic information were obtained by
direct interview and by reviewing patients' clinical records
and videos.3. Results
A total of 73 patients (28 females, 45 males) were enrolled. All
but three patients (1 from Albania, 1 from China and 1 from
India) were of Italian origins. The mean age of onset of dys-
tonia was 10.2 (±5.1) years andmean age at the time of genetic
testingwas 33 (±14.2) years. Mean disease duration at the time
of enrollment was 22.7 (±12.8) years.
Parental consanguinity was documented in 4 (5.5%) pa-
tients, possible in 1 (1.4%) and absent in 68 (93.1%) enrolled
subjects. Eight patients (11%) had at least one sibling affected
by dystonia, indicating a possible recessive pattern of inheri-
tance, but in none of these cases parental consanguinity was
documented.
Clinical features of enrolled subjects are shown in Table 1.
Onset of dystonia (defined by direct patients' observation
or review of records) was in the lower limbs in 26% of cases;
upper limbs, the cervical region and a multifocal involvement
were present at the beginning in 15% of patients each,
whereas in 20.5% of patients a generalized distribution was
noted since the first clinical evaluation.
Sanger sequencing did not reveal exonic HPCA mutations
in any subject enrolled. Exonic or genomic rearrangements
involving the HPCA gene were not ruled out.4. Discussion
Since the discovery of TOR1A gene in 1997,9 27 dystonia loci
have been mapped, and 17 dystonia-related genes have been
identified. DYT1 mutations remain the most common genetic
cause of dystonia, especially in Ashkenazi Jews.10 However,
for some recently identified genes, a limited number of
mutated patients have been reported, and the pathogenic role
of some of them has been questioned.11 In 2015 HPCA was
discovered in a consanguineous Sephardic Jewish kindred
including three affected siblings with childhood-onset
Table 1 e Clinical features of subjects enrolled.
Site of onset
Cranial 2 (2.7%)
Oro-mandibular 2 (2.7%)
Cervical 11 (15.1%)
Trunk 2 (2.7%)
Upper limb 11 (15.1%)
Lower limb 19 (26%)
Multifocal 11 (15.1%)
Generalized 15 (20.5%)
Family history
N 57 (78.1%)
Y 12 (16.4%)
P 4 (5.5%)
Consanguinity
N 68 (93.1%)
Y 4 (5.5%)
P 1 (1.4%)
P: possible.
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without major functional limitations in adulthood. The age of
onset varied between 1 and 8 years and sites initially affected
were lower limbs and the cranial-cervical region; the upper
body resulted more markedly affected in adulthood.
Based on the observation that the only cases described so
far were affected since childhood, we selected a population of
dystonic patients with onset during childhood and adoles-
cence according to the current classification of dystonia1 to
assess the mutational frequency of this gene in a specific age-
selected population. We excluded all probands with clear
autosomal dominant inheritance of dystonia, but purposely
included in the study also sporadic cases, who could also have
inherited recessive mutations from unaffected healthy par-
ents, even in the absence of obvious consanguinity or of
positive family history. The only HPCA mutational screening
available in the literature has been recently published by
Dobricic and colleagues7 and included 435 patients with iso-
lated dystonia, of which 107 were 20 years at the time of
disease onset. None of the patients enrolled resulted positive
for HPCA mutations.
Similarly, we failed to identifyHPCA pathogenic variants in
any of the 73 tested patients, indicating that mutations in this
gene are a very uncommon in childhood-onset dystonia, as
observed for other recently identified dystonia genes. For
example, only 53 GNAL-positive patients have been reported
since the original description of the gene in 2012,12 and only 10
ANO-3 positive patients have been fully characterized clini-
cally.13 Notably, four of them had childhood onset dystonia,
ranging from 3 to 6 years, but no dedicated studies in children
are available.
We acknowledge that multiplex ligation-dependent probe
amplification (MLPA) detectingHPCA deletions or duplications
was not performed in our patients, thus HPCA mutational
frequency could have overall been underestimated; however,
no HPCA exonic or genomic rearrangements have been re-
ported in the literature so far.At present, it is difficult to foresee whether HPCA genetic
testing would be advisable in sporadic or familial recessive
cases with childhood-onset dystonia, and more extensive
studies are warranted to assess HPCA mutational frequency
and related phenotypes in dystonic patients from different
populations.Conflict of interest
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